Elanco Animal Health (ELAN) Interest Coverage Ratio (2018 - 2026)
Elanco Animal Health's (ELAN) quarterly Interest Coverage Ratio came in at 5.39 in Q1 2026, down 13.48% year-on-year from 6.22 in Q1 2025, and up 172.71% quarter-over-quarter from 1.98 in Q4 2025.
Elanco Animal Health (ELAN) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Interest Coverage Ratio across 9 years of filings, most recently posting 5.39 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 5.39, down 13.48% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.6 (up 198.59% YoY), and the FY2025 annual result was 3.61, up 156.05% from the prior year.
- Interest Coverage Ratio came in at 5.39 for Q1 2026 at Elanco Animal Health, up from 1.98 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 6.22 in Q1 2025 to a low of 22.0 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 7.43 (2022), against an average of 4.87.
- Across the five-year window, Interest Coverage Ratio slumped 155.81% in 2023 and soared 181.68% in 2025, its largest moves.
- Elanco Animal Health's Interest Coverage Ratio stood at 8.66 in 2022, then dropped by 10.8% to 9.6 in 2023, then decreased by 25.04% to 12.0 in 2024, then soared by 116.46% to 1.98 in 2025, then jumped by 172.71% to 5.39 in 2026.
- The last three Interest Coverage Ratio figures came in at 5.39 (Q1 2026), 1.98 (Q4 2025), and 3.21 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 9.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.39 |
| Dec 31, 2025 | 1.98 |
| Sep 30, 2025 | 3.21 |
| Jun 30, 2025 | 4.60 |
| Mar 31, 2025 | 6.23 |
| Dec 31, 2024 | -12.00 |
| Sep 30, 2024 | 1.16 |
| Jun 30, 2024 | -8.11 |
| Mar 31, 2024 | -7.62 |
| Dec 31, 2023 | -9.60 |
| Sep 30, 2023 | -22.00 |
| Jun 30, 2023 | -6.93 |
| Mar 31, 2023 | -6.03 |
| Dec 31, 2022 | -8.66 |
| Sep 30, 2022 | -8.60 |
| Jun 30, 2022 | -7.43 |
| Mar 31, 2022 | -8.35 |
| Dec 31, 2021 | -11.55 |
| Sep 30, 2021 | -10.53 |
| Jun 30, 2021 | -13.13 |